PhaseBio Pharmaceuticals: Q1 Earnings Insights

Benzinga2022-05-16

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

PhaseBio Pharmaceuticals beat estimated earnings by 65.15%, reporting an EPS of $-0.23 versus an estimate of $-0.66.

Revenue was up $117.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.31 which was followed by a 5.0% drop in the share price the next day.

Here's a look at PhaseBio Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.59	-0.61	-0.48	-0.69
EPS Actual	-0.90	-0.66	-0.60	-0.87
Revenue Estimate	1.97M	1.07M	4.02M	30.00K
Revenue Actual	158.00K	335.00K	10.34M	0

To track all earnings releases for PhaseBio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2235400126?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-05-16 19:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2235400126","market":"hk","top_or_hot":-1,"title":"PhaseBio Pharmaceuticals: Q1 Earnings Insights","media":"Benzinga","content":"<html><body>\n<p><strong>PhaseBio Pharmaceuticals</strong> (NASDAQ:PHAS) reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.</p>\n<p>Here's what investors need to know about the announcement.</p>\n<h3>Earnings</h3>\n<p>PhaseBio Pharmaceuticals beat estimated earnings by 65.15%, reporting an EPS of $-0.23 versus an estimate of $-0.66.</p>\n<p>Revenue was up $117.00 thousand from the same period last year.</p>\n<h3>Past Earnings Performance</h3>\n<p>Last quarter the company missed on EPS by $0.31 which was followed by a 5.0% drop in the share price the next day.</p>\n<p>Here's a look at PhaseBio Pharmaceuticals's past performance:</p>\n<table>\n<thead>\n<tr>\n<th><strong>Quarter</strong></th>\n<th><strong>Q4 2021</strong></th>\n<th><strong>Q3 2021</strong></th>\n<th><strong>Q2 2021</strong></th>\n<th><strong>Q1 2021</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><strong>EPS Estimate</strong></td>\n<td>-0.59</td>\n<td>-0.61</td>\n<td>-0.48</td>\n<td>-0.69</td>\n</tr>\n<tr>\n<td><strong>EPS Actual</strong></td>\n<td>-0.90</td>\n<td>-0.66</td>\n<td>-0.60</td>\n<td>-0.87</td>\n</tr>\n<tr>\n<td><strong>Revenue Estimate</strong></td>\n<td>1.97M</td>\n<td>1.07M</td>\n<td>4.02M</td>\n<td>30.00K</td>\n</tr>\n<tr>\n<td><strong>Revenue Actual</strong></td>\n<td>158.00K</td>\n<td>335.00K</td>\n<td>10.34M</td>\n<td>0</td>\n</tr>\n</tbody>\n</table>\n<p>To track all earnings releases for PhaseBio Pharmaceuticals visit their earnings calendar here.</p>\n<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>\n</body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PhaseBio Pharmaceuticals: Q1 Earnings Insights</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhaseBio Pharmaceuticals: Q1 Earnings Insights\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-16 19:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/22/05/27216239/phasebio-pharmaceuticals-q1-earnings-insights><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.\nHere's what investors need to know about the announcement.\nEarnings\nPhaseBio ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/22/05/27216239/phasebio-pharmaceuticals-q1-earnings-insights\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.benzinga.com/news/earnings/22/05/27216239/phasebio-pharmaceuticals-q1-earnings-insights","article_id":"2235400126","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2235400126","pubTimestamp":1652702076,"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" \n\nPhaseBio Pharmaceuticals (NASDAQ:PHAS) reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.\n\nHere&#39;s what investors need to know about the announcement.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"PhaseBio Pharmaceuticals：第一季度收益洞察","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHAS":0.9},"content_text":"PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported its Q1 earnings results on Monday, May 16, 2022 at 06:00 AM.\nHere's what investors need to know about the announcement.\nEarnings\nPhaseBio Pharmaceuticals beat estimated earnings by 65.15%, reporting an EPS of $-0.23 versus an estimate of $-0.66.\nRevenue was up $117.00 thousand from the same period last year.\nPast Earnings Performance\nLast quarter the company missed on EPS by $0.31 which was followed by a 5.0% drop in the share price the next day.\nHere's a look at PhaseBio Pharmaceuticals's past performance:\n\n\n\nQuarter\nQ4 2021\nQ3 2021\nQ2 2021\nQ1 2021\n\n\n\n\nEPS Estimate\n-0.59\n-0.61\n-0.48\n-0.69\n\n\nEPS Actual\n-0.90\n-0.66\n-0.60\n-0.87\n\n\nRevenue Estimate\n1.97M\n1.07M\n4.02M\n30.00K\n\n\nRevenue Actual\n158.00K\n335.00K\n10.34M\n0\n\n\n\nTo track all earnings releases for PhaseBio Pharmaceuticals visit their earnings calendar here.\nThis article was generated by Benzinga's automated content engine and reviewed by an editor.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2235400126"}